Life sciences membership organisation OBN (UK) will be holding in-person event BioTrinity 2023 in London on April 25-26.
The conference will feature two tracks: ‘Scientific’, showcasing innovation across eight core therapy areas, and ‘Life Sciences Business & Investment’.
Key features will include:
- Showcase presentations from R&D companies at series A stage across oncology, neuroscience, microbiome, inflammatory diseases, rare diseases, infectious diseases, medtech and cell and gene therapy
- A ‘Life Science Business & Investment’ track featuring panel discussions on regulatory, investment and exit trends, Green Science, and ESG
- Three days of in-person and virtual one-to-one partnering meetings
- Sponsor exhibitions
- On and offsite networking opportunities including the BioTrinity Networking Party on 25 April
Stuart Rose, CEO of OBN, said: “We have a first-class speaker line-up and excellent delegate numbers which really shows that the appetite for in-person events is undiminished. We are looking forward to coming together to network, collaborate, share cutting-edge knowledge and to catalyse growth across the UK life sciences industry. We would like to thank our supporters and sponsors for making BioTrinity an ongoing success, and we look forward to welcoming everyone in April.”
